MARGINUM
Pioneering the next-generation quantitative surgical techniques
We enable safe and efficient monitoring of tissues during cancer surgery without compromising workflows.
Rethinking surgery.
Marginum is developing groundbreaking tissue recognition technology, especially for oncological surgery.
Our technology assists in safe and efficient identification of cancerous tissue with minimal damage to healthy tissues.
Our Solutions
Unforeseen control
Precise detection of tissue without additional invasive steps – based on internationally awarded research.
LATEST NEWS & PRESS
-
Marginum receives Export2X Internationalisation Award
Read the article : Marginum receives Export2X Internationalisation AwardMarginum has received the 2026 Export2X Internationalisation Award, recognising its rapid growth and expansion into global markets.
-
Marginum signs U.S. Distribution Agreement with ABS Med
Read the article : Marginum signs U.S. Distribution Agreement with ABS MedABS Med has partnered with Marginum to support the planned distribution of HIVEN® across key Midwestern U.S. states, subject to FDA authorisation.
-
Marginum HIVEN® wins Red Dot Product Design Award
Read the article : Marginum HIVEN® wins Red Dot Product Design AwardMarginum wins the prestigious Red Dot Design Award for HIVEN® device, recognising its innovation in advancing cancer surgery through user-centred design.
-
Marginum Launches U.S. Clinical Trial with First Patient Treated
Read the article : Marginum Launches U.S. Clinical Trial with First Patient TreatedMarginum launches a U.S. clinical study with the HIVEN® device at the University of Illinois Hospital & Clinics (UI Health) in Chicago.
-
Strategic distribution partnership with ALMEDA
Read the article : Strategic distribution partnership with ALMEDAALMEDA, a Prague-based medical equipment distributor, has partnered with Marginum to distribute its HIVEN® device in the Czech Republic and Slovakia.
-
First-in-Human Study: HIVEN® Performance and Safety Results
Read the article : First-in-Human Study: HIVEN® Performance and Safety ResultsA first-in-human study shows that HIVEN®-based aspirate tissue monitoring provides nearly 5 times more fluorescence information than visual guidance alone.
ABOUT US
Dedication
to improve
Marginum is enabling better surgical performance and patient outcomes to answer the globally growing need for efficient oncological treatments.
TRUSTED BY LEADING MEDICAL INSTITUTIONS WORLDWIDE
FOR INVESTORS
We are the pioneers of aspirate tissue monitoring
Founded in 2020, Marginum is reforging the technology of oncological surgery.
With the developed tissue detection technology for surgery, Marginum aims to make a real impact by helping millions of patients and surgical professionals around the globe.
OUR PARTNERS
Enabling disruptive innovations
CONTACT
Contact us and learn more about the next steps of our mission.
Location: Kuopio, Finland
Email: info@marginum.com